Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Ludvig P. Muren"'
Autor:
Casper Dueholm Vestergaard, Ulrik Vindelev Elstrøm, Ludvig Paul Muren, Jintao Ren, Ole Nørrevang, Kenneth Jensen, Vicki Trier Taasti
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 32, Iss , Pp 100658- (2024)
Background and Purpose: Poor image quality of cone-beam computed tomography (CBCT) images can hinder proton dose calculation to assess the influence of anatomy changes. The aim of this study was to evaluate image quality and proton dose calculation a
Externí odkaz:
https://doaj.org/article/0e4c5a7a19524ff487329a0f150e9bfc
Autor:
Ludvig P. Muren
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 29, Iss , Pp 100559- (2024)
Externí odkaz:
https://doaj.org/article/0696a04e79c34f85bcc2b73331904e22
Autor:
Barbara Knäusl, Ludvig P. Muren
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 29, Iss , Pp 100560- (2024)
Externí odkaz:
https://doaj.org/article/f0d4c34cbe524d32a17d43f734e78b3b
Autor:
Martin F. Fast, Suzanne Lydiard, Judit Boda-Heggemann, Stephanie Tanadini-Lang, Ludvig P. Muren, Catharine H. Clark, Oliver Blanck
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 28, Iss , Pp 100508- (2023)
Externí odkaz:
https://doaj.org/article/b9eff3e91a594bb9b306323f9aa743b7
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 27, Iss , Pp 100480- (2023)
Proton arc therapy (PAT) is currently explored for clinical implementation, despite its associated low-dose bath. This study therefore aimed at evaluating the risk of radiation-induced second primary cancer (SPC) for PAT in pediatric brain tumor pati
Externí odkaz:
https://doaj.org/article/32651b13adbc4d2aaad73150c468cd81
Autor:
Andreas H. Handeland, Daniel J. Indelicato, Lars Fredrik Fjæra, Kristian S. Ytre-Hauge, Helge Egil S. Pettersen, Ludvig P. Muren, Yasmin Lassen-Ramshad, Camilla H. Stokkevåg
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 27, Iss , Pp 100466- (2023)
Background and Purpose: Radiation-induced brainstem necrosis after proton therapy is a severe toxicity with potential association to uncertainties in the proton relative biological effectiveness (RBE). A constant RBE of 1.1 is assumed clinically, but
Externí odkaz:
https://doaj.org/article/2589b8764a484c77838a68acc284850d
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 27, Iss , Pp 100457- (2023)
Externí odkaz:
https://doaj.org/article/1c286b4bff744afd87ba58073474e0d7
Autor:
Sofie Tilbæk, Ludvig Paul Muren, Anne Vestergaard, Liliana Stolarczyk, Heidi S. Rønde, Tanja S. Johansen, Jimmi Søndergaard, Morten Høyer, Jan Alsner, Lise Nørgaard Bentzen, Stine Elleberg Petersen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 41, Iss , Pp 100632- (2023)
The Danish Prostate Cancer Group is launching the randomized trial, PROstate PROTON Trial 1 (NCT05350475), that compares photons and protons to the prostate and pelvic lymph nodes in treatment of high-risk prostate cancer. The aim of the work describ
Externí odkaz:
https://doaj.org/article/476f69b5d34e42439e03be89787695cc
Autor:
Casper Dueholm Vestergaard, Ludvig Paul Muren, Ulrik Vindelev Elstrøm, Jacob Graversen Johansen, Vicki Trier Taasti
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 26, Iss , Pp 100441- (2023)
Background and Purpose: Proton therapy is sensitive to range uncertainties, which typically are accounted for by margins or robust optimization, based on tissue-independent uncertainties. However, range uncertainties have been shown to depend on the
Externí odkaz:
https://doaj.org/article/a9099d42cf164af787d40c61761cb544
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 24, Iss , Pp 118-120 (2022)
Externí odkaz:
https://doaj.org/article/d1bc910692f14957b56d3ad5f57803af